A Race Against Time: EMA Wants 'Immediate' Action On Brexit Relocation Challenges
The EMA has described some of the practical challenges it will face when it is forced to relocate from London to another EU country as a result of Brexit, including the fit-out of the new premises and the accommodation and schooling needs of its staff and their families. It will have only 17 months to complete the move and be up and running.
You may also be interested in...
The EMA has published its analysis of the 19 bids to host the agency post-Brexit, which confirms reports that five cities – Amsterdam, Barcelona, Copenhagen, Milan and Vienna – would bring the best result in terms of retaining staff when it relocates. The agency has expressed concern that low retention rates could hit operations and result in lower fee income, requiring an injection of cash from the EU budget.
The UK life sciences trade group says the “ill-considered” guidance will result in duplicative and costly repetition and dent industry’s confidence in the government’s competence.
The Australian government is investing in two candidate vaccines being developed in Melbourne, French firm Avaxia is looking at the virucidal potential of an antibacterial compound, and Canada has ordered millions of specialist vials and syringes from an advanced materials science firm based in Alabama.